Cassava sciences to hold conference call to discuss recent developments and provide a company update on thursday, august 8, 2024 at 8:30 am et

Austin, texas, aug. 01, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, announced today that it will hold a conference call on thursday, august 8th at 8:30 a.m. eastern time.
SAVA Ratings Summary
SAVA Quant Ranking